
HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study
Author(s) -
Frederick L. Altice,
R. Douglas Bruce,
Gregory M. Lucas,
Paula J. Lum,
P. Todd Korthuis,
Timothy P. Flanigan,
Chinazo O. Cunningham,
Lynn E. Sullivan,
Pamela Vergara-Rodriguez,
David A. Fiellin,
Adan Cajina,
Michael Botsko,
Vijay Nandi,
Marc N. Gourevitch,
Ruth Finkelstein
Publication year - 2011
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e318209751e
Subject(s) - medicine , buprenorphine , (+) naloxone , methadone , opioid , viral load , addiction , young adult , human immunodeficiency virus (hiv) , longitudinal study , generalized estimating equation , psychiatry , immunology , receptor , statistics , mathematics , pathology
Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes.